Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

VRB-101

A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Verdiva Bio Dev Limited · Phase 2 · Terminated · Enrollment 8

NCT07553299

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
VRB-101 (Active Arm 1)n/rn/rn/rn/r
VRB-101 (Active Arm 2)n/rn/rn/rn/r
VRB-101 (Active Arm 3)n/rn/rn/rn/r
Placebon/rn/rn/rn/r

Not shown

  • VRB-101 (Active Arm 1): endpoint not reported
  • VRB-101 (Active Arm 2): endpoint not reported
  • VRB-101 (Active Arm 3): endpoint not reported
  • Placebo: endpoint not reported